Biotech

All Articles

Sanofi's $80M bank on Key dystrophy medication ends in period 3 fail

.Just 4 months after Sanofi bet $80 thousand in ahead of time money on Key Therapeutics' losmapimod,...

Oncternal equity sinks 60% amid cutbacks, test firings

.Cancer cells business Oncternal Rehabs is actually folding all its clinical tests as well as laying...

Novo Nordisk barrages 'amazing' weight loss result for dual-acting oral drug in very early test

.Novo Nordisk has raised the cover on a stage 1 trial of its own dental amylin and GLP-1 receptor co...

AbbVie takes legal action against BeiGene over blood stream cancer cells medicine classified information

.Only a few short weeks after succeeding an FDA Fast lane tag for its own investigational BTK degrad...

Lilly delivers one-two hit with 2nd tranche of favorable records on once a week the hormone insulin prospect

.Not long after a beneficial information decline for Eli Lilly's efsitora alfa, the Indianapolis-bas...

BridgeBio reduces gene treatment finances as professional information dissatisfy

.BridgeBio Pharma is slashing its genetics therapy budget plan as well as pulling back coming from t...

GSK relinquishes HSV vaccination really hopes after period 2 fall short, transferring nationality to Moderna, BioNTech

.GSK's effort to create the very first vaccination for herpes simplex infection (HSV) has actually e...

GSK's long-acting bronchial asthma drug halved attacks in period 3

.GSK's long-acting asthma procedure has been presented to halve the amount of attacks in a set of pe...

AstraZeneca, Daiichi unpack Dato-DXd's total survival fall short

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually failed t...